by Long Island Attorney Paul A. Lauto, Esq.
Plaintiff Barbara Davids, suffering from breast cancer, commenced taking the drug Zometa which is manufactured by Novartis Pharmaceuticals Corp. The purpose for taking the drug was to suppress metastatic damage to her bones. Thereafter, Davids developed osteonecrosis of her jaw, which her doctors opined was caused by the drug Zometa.
Davids sued Novartis Pharnaceuticals Corp. alleging that they knew Zometa caused osteonecrosis dating back to the initial drug testing period. Further, that Zometa's label and instructions in violation of government mandated guidelines, failed to adequately warn and disclose the potential dangers associated with taking the drug.
Defendant argued that the evidence presented, did not adequately prove that Zometa caused plaintiff's osteonecrosis. Defendant also maintained, that the durg's label and packaging did sufficiently warn of the drug's potential effects.
Read the full article in our latest Scales of Justice blog at www.liattorney.com/scales-of-justice.html.